Zobrazeno 1 - 4
of 4
pro vyhledávání: '"I. S. Zuzgin"'
Autor:
L. P. Mendeleeva, V. G. Savchenko, L. S. Lubimova, I. A. Demidova, B. V. Afanassiev, L. S. Zubarovskaya, T. P. Zagoskina, I. S. Zuzgin, T. S. Konstantinova, V. A. Lapin, I. A. Lisukov, A. B. Loginov, N. A. Obidina, V. A. Rossiev, S. V. Shamansky
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 38-45 (2022)
Russian Interregional Register of hematopoietic stem cell transplantation was established in 2000. 11 transplant centres from 7 Russian cities are including in Register now. In this analysis we applied transplant activity survey data from 01.01.1996
Externí odkaz:
https://doaj.org/article/3884df5b6b8f4ec1aa9ee0195d96e778
Autor:
S. N. Khostelidi, A. G. Volkova, M. O. Popova, T. S. Bogomolova, A. S. Kolbin, E. G. Boychenko, N. V. Medvedeva, E. I. Podoltseva, A. V. Klimovich, M. B. Belogurova, I. S. Zuzgin, L. S. Zuborovskaya, N. V. Vasilyeva, N. N. Klimko
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 7-8, Pp 23-29 (2020)
Thirty four patients with mucormycosis in 10 hospitals of St. Petersburg were observed in 2004-2013. The most frequent underlying diseases of mucormycosis were acute leukoses (64%). In 100% of the patients mucormycosis developed as a nosocomial infec
Externí odkaz:
https://doaj.org/article/58e3b0c56fe04e81b50e9775d921e0b3
Autor:
N. N. Klimko, S. N. Khostelidi, O. V. Shadrivova, T. S. Bogomolova, Y. L. Avdeenko, A. G. Volkova, M. O. Popova, I. A. Mihailova, A. S. Kolbin, E. G. Boychenko, N. V. Medvedeva, E. I. Podoltseva, A. V. Klimovich, M. B. Belogurova, I. S. Zuzgin, O. S. Uspenskaya, V. N. Semelev, N. I. Ponomoreva, G. K. Abdilova, L. S. Zuborovskaya, B. V. Afanasiev
Publikováno v:
Онкогематология, Vol 12, Iss 2, Pp 14-22 (2017)
In 2004–2016 we prospectively observed 59 oncohematology patients with mucormycosis; 21 children and 38 adults. The most frequent underlying diseases were acute myeloid leukemia and acute lymphoblastic leukemia (64 %); and main risk factors were с
Externí odkaz:
https://doaj.org/article/e9d1769078024c53bf8a5840bfcc7263
Autor:
M S Motalkina, S A Kulyova, S M Alexeev, I S Zuzgin, L V Filatova, A S Zhabina, A A Zverkova, I V Ishmatova, A A Rjazankina, A S Artemyeva, T Yu Semiglazova
Publikováno v:
Современная онкология, Vol 17, Iss 2, Pp 54-56 (2015)
In our clinical example, we studied the possibility of early treatment intensification, through the use of a new combination pegfilgrastim and plerixafor as a regime of mobilization. Within 4 days (after a single injection pegfilgrastim 6 mg in D1) w
Externí odkaz:
https://doaj.org/article/6597e0dcba3e4b39b7faf3c59ad667c7